Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Clinical and Vaccine Immunology : CVI
Shahida BaqarBeth Kirkpatrick

Abstract

The recrudescence of infection with Campylobacter jejuni after appropriate antibiotic treatment has not been previously reported in an immunocompetent adult. We present the complete clinical, microbiologic, and immunologic evaluation of a closely monitored healthy male with recrudescent C. jejuni infection occurring in the absence of immunodeficiency following experimental infection with a well-characterized strain. After antibiotic treatment, the initial infection was clinically cleared and microbiologically undetectable. Subsequently, two episodes of recrudescence occurred, with no change in in vitro antibiotic sensitivity being detected. The immune responses of the individual were compared to those of other participants in the experimental infection study: innate immune responses, including fecal cytokines and C-reactive protein, were intact; however, measures of Campylobacter-specific adaptive immune responses were absent, including serum antibodies, antibody-secreting cells, and in vitro gamma interferon responses. No primary or secondary immunodeficiency was identified. Recrudescent Campylobacter infections after treatment may be more common than has previously been appreciated. This work adds to our understanding of the ...Continue Reading

References

Jan 1, 1992·Scandinavian Journal of Infectious Diseases·G KapperudS Aasen
Sep 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P J KerstensJ W van der Meer
Apr 1, 1986·European Journal of Clinical Microbiology·H PichlerD Wolf
Mar 1, 1988·The Journal of Infectious Diseases·R E BlackM J Blaser
Feb 1, 1985·Journal of Clinical Microbiology·M J BlaserJ Amer
Mar 1, 1983·American Journal of Diseases of Children·C H PaiM I Marks
Jun 1, 1984·Annals of Internal Medicine·R J JohnsonM J Blaser
Mar 1, 1983·Annals of Internal Medicine·M J BlaserJ R Allen
Aug 1, 1983·American Journal of Diseases of Children·I MelamedZ Spirer
Feb 1, 1982·Annals of Internal Medicine·D J Ahnen, W R Brown
Apr 17, 1993·Lancet·V HammarströmL Hammarström
Aug 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J N MaslowR D Arbeit
Dec 13, 1997·The Journal of Infectious Diseases·B M Allos
Feb 23, 2000·FEMS Immunology and Medical Microbiology·B JanvierJ Louis Fauchère
Jul 13, 2000·International Journal of Sports Medicine·M Gleeson, N C Bishop
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R L GuerrantUNKNOWN Infectious Diseases Society of America
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S BaqarJ R Murphy
Apr 6, 2002·Rheumatology·T HannuM Leirisalo-Repo
Sep 10, 2003·The Journal of Infection·Fajer Subah Al-SalloomMoiz Bakhiet
Jun 23, 2004·Emerging Infectious Diseases·Jørgen EngbergVivian Fussing
Aug 25, 2005·British Journal of Sports Medicine·A J McKuneA A Wadee
Nov 17, 2006·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Bruce V TaylorAlistair McGregor
Jan 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R TribbleDaniel A Scott
Jan 26, 2007·Journal of Clinical Microbiology·Sitara Swarna Rao AjjampurGagandeep Kang
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anders TernhagKarl Ekdahl
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Guillermo M Ruiz-Palacios
May 23, 2007·Infection and Immunity·Frédéric PolyPatricia Guerry
Mar 4, 2008·Journal of Bacteriology·Joshua A Fields, Stuart A Thompson
Oct 22, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R TribbleBeth D Kirkpatrick

❮ Previous
Next ❯

Citations

Jul 11, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Beth D KirkpatrickDavid R Tribble
Dec 20, 2012·Infection and Immunity·Alexander C MauePatricia Guerry
Jun 18, 2010·Journal of Clinical Microbiology·J C LindowB D Kirkpatrick
Nov 18, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joanna E RimmerMark S Riddle
Mar 29, 2018·Nature Microbiology·Alexander A CroftsM Stephen Trent
Jun 13, 2015·Clinical Microbiology Reviews·Nadeem O KaakoushSi Ming Man
May 11, 2016·Antimicrobial Agents and Chemotherapy·Juan Aguilar-CompanyBenito Almirante
Dec 3, 2010·Current Opinion in Gastroenterology·Beth D Kirkpatrick, David R Tribble
Sep 28, 2016·World Journal of Gastroenterology : WJG·Anand KumarGireesh Rajashekara
Aug 9, 2019·The American Journal of Tropical Medicine and Hygiene·Jesús D RojasFrédéric M Poly
Jun 24, 2020·Scientific Reports·Clare R BarkerTimothy J Dallman
Jan 11, 2020·Immune Network·Amber Hameed
Oct 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy L McMurryJames A Platts-Mills

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D R TribbleB D Kirkpatrick
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
A van BelkumEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM)
© 2022 Meta ULC. All rights reserved